We have just over 100 million market cap at over $3 a share, so, 330 million market cap at $10 does not seem unreasonable I suppose. I haven't seen anyone work the numbers in any reasonable way. Potential sales based on liver cancer patients, etc. Then the timeline and sales for breast cancer and so on. Maybe, I missed a previous posting.
Market Data 
Markets 
